AIで多発性硬化症の脳病変を可視化(Study: With the help of AI, MS researchers can now see brain lesions they knew were there but couldn’t previously see on scans)

ad

2026-07-07 バッファロー大学(UB)

米国バッファロー大学の研究チームは、人工知能(AI)を用いてMRI画像から多発性硬化症(MS)の進行を高精度で評価する新たな解析手法を開発した。従来のMS評価は白質病変に重点が置かれてきたが、本研究では認知機能や身体機能の低下と深く関係する灰白質(グレーマター)の変化に着目した。AIはMRI画像から灰白質の微細な萎縮や構造変化を自動解析し、人の目では検出が難しい病変の進行を高精度に把握できることが示された。この手法により、疾患の進行予測や患者ごとの重症度評価が向上し、治療効果の判定や個別化医療への応用が期待される。また、画像解析の効率化によって臨床医の負担軽減や診断の標準化にも寄与すると考えられる。研究チームは、今後さらに多施設での検証を進めることで、日常診療への導入や、他の神経変性疾患への応用も視野に入れている。本研究は、AIと医用画像解析を組み合わせた神経疾患診断の高度化に向けた重要な成果である。

<関連情報>

多重コントラスト後処理と深層学習を用いた多発性硬化症MRIデータセットにおける皮質病変の定量化 Quantifying cortical lesions in multiple sclerosis MRI datasets using multi-contrast post-processing and deep learning

Michael G. Dwyer,Niels Bergsland,Alexander Bartnik,Dejan Jakimovski,Samantha Noteboom,Menno M. Schoonheim,Martijn D. Steenwijk,Jinglan Pei,David Clayton & Robert Zivadinov
Communications Medicine  Published:07 July 2026
DOI:https://doi.org/10.1038/s43856-026-01683-7

AIで多発性硬化症の脳病変を可視化(Study: With the help of AI, MS researchers can now see brain lesions they knew were there but couldn’t previously see on scans)

Abstract

Background
Multiple sclerosis (MS) is a chronic neurological disease affecting both white and gray matter of the central nervous system. Despite the well-established involvement of cortical lesions in MS, feasibility limitations in their visualization on typical magnetic resonance imaging (MRI) protocols prevent their evaluation in nearly all clinical trials. Recently, several post-processing methods, including synthetic contrasts and artificial intelligence (AI)-based approaches, have shown potential for enhancing cortical lesion detection on conventional MRI data. These methods have the potential to reanalyze existing clinical-trial data to answer key mechanistic questions about both MS development and about treatment effects.

Methods
We sought to evaluate the feasibility of combining and extending existing methods into a unified framework for analysis using the data from the large, multicenter, phase 3 ORATORIO trial (full n = 732, age=44.6 ± 8.0; development subset n = 80, age=46.6 ± 7.1). We specifically evaluated three of the most promising of them – fluid-attenuated inversion recovery squared (FLAIR2), T1/T2 ratio, and artificial intelligence-derived double inversion recovery (AI-DIR) – and introduced a new combined contrast called multi-modal cortical lesion enhanced (MMCLE). We also harnessed transformer-based semantic segmentation to improve automated detection and delineation of these lesions.

Results
At baseline, we detected 14.8 + /−20.72 lesions per participant, with 86.0% true positive rate and 8.4% false positive rate across subjects for blinded MMCLE, using simultaneous review of all contrasts as the reference. High reproducibility was observed across field strengths and acquisition types (ICC 88.8-92.5%).

Conclusions
We confirmed that cortical lesions can be clearly visualized and quantified with these methods. Using deep learning, we also confirmed that the simultaneous use of multiple contrasts improves quantification.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました